Bristol-Myers announces extension of expiration date for Celgene exchange offer
Bristol-Myers Squibb announced the extension of the expiration date of the offers to exchange notes issued by Celgene Corporation for up to $19,850,000,000 aggregate principal amount of new notes to be issued by Bristol-Myers Squibb. May 24, 2019